Section

Markets

Chip and Meta gains helped the Nasdaq and S&P 500 rise, while renewed U.S.-Iran tensions pushed crude higher and weighed on the Do...

By Amanda Ross 2 months ago

ETF Action’s Mike Akins told CNBC that lagging software, cloud, disruptive tech and Magnificent Seven shares could regain ground a...

By Amanda Ross 2 months ago

The Hangzhou startup is pursuing non-invasive brain-computer interfaces as China puts neurotechnology into its industrial policy f...

By Sarah Jenkins 2 months ago

The new 530A accounts offer tax-deferred investing for minors, with federal seed money for some newborns and annual contribution l...

By Sarah Jenkins 2 months ago

CNBC’s 2026 study gave quality of life greater weight as employers weigh talent access, health, safety and childcare in location d...

By Amanda Ross 2 months ago

Self-optimization trends are spreading as the wellness economy grows, but clinicians say extreme goal-setting can worsen anxiety,...

By Amanda Ross 2 months ago

The 21st Century ROAD to Housing Act became law without President Trump’s signature, targeting supply, financing access and instit...

By Marcus V. Thorne 2 months ago

Berkshire Hathaway’s B shares are down 1.8% in 2026, while the S&P 500 is up 10.7%, according to CNBC calculations.

By Sarah Jenkins 2 months ago

Novo Nordisk has agreed to evaluate Vivani’s experimental semaglutide implant, a long-acting device still awaiting human trial dat...

By Marcus V. Thorne 2 months ago

Amazon’s largest cuts have coincided with wider tech layoffs and AI-driven restructuring, leaving some former employees facing lon...

By Marcus V. Thorne 2 months ago

A late-stage Wainua trial failure erased more from AstraZeneca’s shares than analysts’ valuation models suggested, putting focus o...

By Marcus V. Thorne 2 months ago

The US president threatened military retaliation while Treasury targeted an alleged financier linked to Iran’s leadership.

By Amanda Ross 2 months ago